NAVB - Navidea Biopharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - NAVB (810509)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2021-04-23
NAVBWitter Malcolm GDirP - Purchase$1.60+10,00057,000+21%+$16,000
2021-03-29
NAVBWitter Malcolm GDirP - Purchase$2.07+21,50047,000+84%+$44,505
2021-03-03
NAVBWitter Malcolm GDirP - Purchase$2.31+15,00025,500+143%+$34,650
2020-12-28
NAVBWitter Malcolm GDirP - Purchase$2.07+5,00010,500+91%+$10,350
2020-08-30
NAVBScott John K Jr.10%P - Purchase$5.00+5,0008,057,3010%+$25,000
2020-02-20
NAVBLatkin JedCEO, COO, CFOP - Purchase$1.08+5,00017,950+39%+$5,400
2020-02-13
NAVBScott John K Jr.10%P - Purchase$0.85+2,373,5298,052,301+42%+$2,017,500
2019-12-06
NAVBScott John K Jr.10%P - Purchase$0.90+555,5555,678,772+11%+$500,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top